Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma

Gracheva MA, Urnova ES, Sinauridze EI, Tarandovskiy ID, Orel EB, Poletaev AV, Mendeleeva LP, Ataullakhanov FI, Balandina AN.

Read more

Eculizumab effect on the hemostatic state in patients with paroxysmal nocturnal hemoglobinuria

Seregina EA, Tsvetaeva NV, Nikulina OF2, Zapariy AP, Erasov AV, Gribkova IV, Orel EB, Ataullakhanov FI, Balandina AN.
Read more

Predicting prothrombotic tendencies in sepsis using spatial clot growth dynamics

Soshitova NP, Karamzin SS, Balandina AN, Fadeeva OA, Kretchetova AV, Galstian GM, Panteleev MA, Ataullakhanov FI.
Read more

Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets

Sinauridze EI1, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV, Ataullakhanov FI.
Read more

Thrombin inhibitors based on single-stranded DNA aptamers

Gribkova IV, Spiridonova VA, Gorbatenko AS, Denisov SS, Ataullakhanov FI, Sinauridze EI.
Read more

Drug-drug interaction of the anti-TFPI aptamer BAX499 and factor VIII: Studies of spatial dynamics of fibrin clot formation in hemophilia A☆

Parunov LA, Soshitova NP, Fadeeva OA, Balandina AN, Kopylov KG, Kumskova MA, Gilbert JC, Schaub RG, McGinness KE, Ataullakhanov FI, Panteleev MA

Read more

Investigation of the phenotype heterogeneity in severe hemophilia A using thromboelastography, thrombin generation, and thrombodynamics

Tarandovskiy ID, Balandina AN, Kopylov KG, Konyashina NI, Kumskova MA, Panteleev MA, Ataullakhanov FI.
Read more

Improvement of spatial fibrin formation by the anti-TFPI aptamer BAX499: changing clot size by targeting extrinsic pathway initiation.

Parunov LA, Fadeeva OA, Balandina AN, Soshitova NP, Kopylov KG, Kumskova MA, Gilbert JC, Schaub RG, McGinness KE, Ataullakhanov FI, Panteleev MA.
Read more